Long-Term Outcome after Autologous Stem Cell Transplantation with Adequate Peripheral Blood Stem Cell Mobilization Using Plerixafor and G-CSF in Poor Mobilizer Lymphoma and Myeloma Patients

Table 3

The mobilization regimens used except when nonapplicable (N/A). Plerixafor dose was 0.24 mg/kg for all patients given at 2200 the night before apheresis.

	1st mobilization attempt			2nd mobilization attempt
G-CSF dose	5 BID μg/kg	10 BID μg/kg	16 BID μg/kg	5 BID μg/kg	10 BID μg/kg
MM, n
Poor mobilizers (𝑛=8); Good mobilizers (𝑛=10)	5; 4	3; 5	0; 1	5; N/A	3; N/A
Lymphoma, n
Poor mobilizers (𝑛=9); Good mobilizers (𝑛=13)^*‡	3; 1	6; 12	0; 0	2; N/A	7; N/A

*One lymphoma control patient had chemotherapy + G-CSF 10 μg/kg twice per day (BID).
^‡In this group of 15 control lymphoma patients, mobilization regimen doses were not available for two patients.